Horizon Investments’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19.8M | Buy |
141,760
+9,445
| +7% | +$1.32M | 0.22% | 77 |
|
|
2025
Q4 | $16.2M | Buy |
132,315
+342
| +0.3% | +$41.6K | 0.21% | 83 |
|
|
2025
Q3 | $14.6M | Buy |
131,973
+29,282
| +29% | +$3.33M | 0.19% | 94 |
|
|
2025
Q2 | $11.4M | Buy |
102,691
+78,030
| +316% | +$8.3M | 0.18% | 90 |
|
|
2025
Q1 | $2.76M | Sell |
24,661
-6,310
| -20% | -$651K | 0.08% | 160 |
|
|
2024
Q4 | $2.86M | Sell |
30,971
-1,854
| -6% | -$167K | 0.08% | 146 |
|
|
2024
Q3 | $2.75M | Buy |
32,825
+614
| +2% | +$46.9K | 0.07% | 135 |
|
|
2024
Q2 | $2.21M | Buy |
32,211
+353
| +1% | +$23.6K | 0.06% | 150 |
|
|
2024
Q1 | $2.33M | Buy |
31,858
+967
| +3% | +$74.4K | 0.06% | 146 |
|
|
2023
Q4 | $2.5M | Buy |
30,891
+4,188
| +16% | +$326K | 0.07% | 124 |
|
|
2023
Q3 | $2M | Buy |
26,703
+7,019
| +36% | +$540K | 0.06% | 121 |
|
|
2023
Q2 | $1.52M | Sell |
19,684
-2,800
| -12% | -$223K | 0.04% | 142 |
|
|
2023
Q1 | $1.87M | Sell |
22,484
-16,707
| -43% | -$1.38M | 0.06% | 120 |
|
|
2022
Q4 | $3.37M | Buy |
39,191
+12,417
| +46% | +$983K | 0.09% | 97 |
|
|
2022
Q3 | $1.65M | Buy |
26,774
+6,768
| +34% | +$427K | 0.05% | 129 |
|
|
2022
Q2 | $1.24M | Sell |
20,006
-3,880
| -16% | -$240K | 0.04% | 164 |
|
|
2022
Q1 | $1.42M | Sell |
23,886
-2,449
| -9% | -$157K | 0.04% | 180 |
|
|
2021
Q4 | $1.91M | Buy |
26,335
+18,218
| +224% | +$1.25M | 0.06% | 151 |
|
|
2021
Q3 | $567K | Buy |
8,117
+383
| +5% | +$26.9K | 0.01% | 294 |
|
|
2021
Q2 | $533K | Sell |
7,734
-24,215
| -76% | -$1.62M | 0.02% | 302 |
|
|
2021
Q1 | $2.06M | Buy |
+31,949
| New | +$2.06M | 0.08% | 112 |
|
|
2020
Q4 | – | Sell |
-8,636
| Closed | -$546K | – | 208 |
|
|
2020
Q3 | $546K | Sell |
8,636
-44,266
| -84% | -$3.07M | 0.02% | 268 |
|
|
2020
Q2 | $4.07M | Buy |
52,902
+41,160
| +351% | +$3.15M | 0.1% | 100 |
|
|
2020
Q1 | $878K | Sell |
11,742
-25,529
| -68% | -$1.76M | 0.04% | 136 |
|
|
2019
Q4 | $2.42M | Buy |
37,271
+31,584
| +555% | +$2.06M | 0.11% | 107 |
|
|
2019
Q3 | $360K | Sell |
5,687
-52,711
| -90% | -$3.45M | 0.01% | 197 |
|
|
2019
Q2 | $3.94M | Buy |
58,398
+483
| +0.8% | +$31.8K | 0.11% | 60 |
|
|
2019
Q1 | $3.77M | Buy |
+57,915
| New | +$3.85M | 0.13% | 58 |
|
|
2017
Q3 | – | Sell |
-13,686
| Closed | -$904K | – | 177 |
|
|
2017
Q2 | $904K | Sell |
13,686
-36
| -0.3% | -$2.4K | 0.05% | 84 |
|
|
2017
Q1 | $932K | Buy |
13,722
+3,152
| +30% | +$222K | 0.06% | 69 |
|
|
2016
Q4 | $757K | Sell |
10,570
-113
| -1% | -$8.4K | 0.05% | 74 |
|
|
2016
Q3 | $845K | Buy |
+10,683
| New | +$868K | 0.06% | 54 |
|
|
2016
Q2 | – | Sell |
-5,559
| Closed | -$511K | – | 117 |
|
|
2016
Q1 | $511K | Buy |
+5,559
| New | +$501K | 0.04% | 68 |
|
Other funds holding GILD
VCM
VPM
Horizon Investments's GILD Position: Q1 2026 in Review
Horizon Investments increased its Gilead Sciences (GILD) stake by 7.1% in Q1 2026, buying an estimated $1.32M and bringing the position to 141,760 shares worth $19.8M. The position accounts for 0.22% of the portfolio, ranked #77.
Horizon Investments first reported a position in GILD in Q1 2016 and has held it in 33 quarters since. 2,315 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Horizon Investments held 141,760 shares of Gilead Sciences worth $19.8M as of Q1 2026.
- Horizon Investments bought 9,445 Gilead Sciences shares in Q1 2026, an estimated $1.32M.
- Gilead Sciences made up 0.22% of Horizon Investments's portfolio in Q1 2026, its #77 holding.
- Horizon Investments first reported a position in Gilead Sciences in Q1 2016 and has held it in 33 quarters since.
- 2,315 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Horizon Investments's 13F filing for Q1 2026, filed 15 May 2026.